Concepedia

A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

Richard Kefford, Jane Beith, Guy A. Van Hazel, Michael Millward, James Trotter, David Wyld, Rada Kusic, Revati Shreeniwas, A. Morganti, Andrea Ballmer,

Investigational New Drugs · 2006 · 63 citations · 20 references

DOI

Concepts

References

20

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson et al. · Journal of Clinical Oncology · 2000 · 1.3K citations

, , +12

Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice

Kiminori Hosoda, Robert E. Hammer, James A. Richardson et al. · Cell · 1994 · 1K citations

, , +4

Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons

Amy Greenstein Baynash, Kiminori Hosoda, Adel Giaid et al. · Cell · 1994 · 957 citations

, , +9

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study

Marie‐Françoise Avril, Steinar Aamdal, Jean‐Jacques Grob et al. · Journal of Clinical Oncology · 2004 · 474 citations

, , +10